SE

Psych Mental Health Flashcards

Major Depressive Disorder (MDD)

  • Diagnosis requires one of two key symptoms:

    • Sad, depressed mood

    • Loss of pleasure or interest in previously enjoyed activities

Mnemonic for Depression Symptoms: SITCH CAPS

  • Sleep disturbances

  • Decreased interest

  • Guilt

  • Decreased energy

  • Decreased concentration

  • Appetite changes

  • Psychomotor symptoms

  • Suicidal ideation

Initial Screening Tool: PHQ-2

  • Two questions focusing on the main symptoms of depression.

  • Positive result leads to the full PHQ-9 assessment.

Assessing Suicidal Ideation

  • Directly ask patients about thoughts of self-harm.

  • Inquire about a specific plan.

    • If a detailed plan exists, refer to the emergency department.

First-Line Medications for MDD

  • Selective Serotonin Reuptake Inhibitors (SSRIs)

  • Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

SSRIs: Key Points

  • Safe for older adults (low side effect profile):

    • Zoloft (sertraline)

    • Lexapro (escitalopram)

  • Avoid in older adults (long half-life):

    • Fluoxetine (Prozac)

  • Most sedating SSRI:

    • Paroxetine (Paxil)

  • Avoid in patients with anxiety:

    • Fluoxetine (Prozac) - may cause nervousness.

  • First-line for pediatric depression (when therapy fails):

    • Fluoxetine (Prozac)

SNRIs: Key Points

  • Commonly used options:

    • Cymbalta (duloxetine)

    • Effexor (venlafaxine)

  • Side effects comparable to SSRIs, but SNRIs can increase blood pressure due to norepinephrine effects.

    • Not ideal for patients with uncontrolled hypertension.

SSRI/SNRI: Patient Education

  • Onset of noticeable effects: 4-6 weeks.

    • If no relief after 4-6 weeks: Increase dose or investigate other conditions.

  • Common side effects: GI issues, sexual dysfunction, potential weight gain.

    • GI effects usually subside after a few weeks.

  • Treatment duration: Typically 6-12 months after symptoms are under control.

Other Antidepressant Drug Classes

  • Tricyclic Antidepressants (TCAs) (e.g., nortriptyline):

    • Not first-line agents due to notable side effects.

    • Side effects: Weight gain, ECG changes.

    • Avoid in older adults due to anticholinergic side effects.

  • Norepinephrine-Dopamine Reuptake Inhibitor (NDRI) - Wellbutrin (bupropion):

    • Uses: MDD, smoking cessation, seasonal affective disorder, and off-label for ADHD.

    • Avoid in patients with anxiety and insomnia (may worsen symptoms).

    • Can reduce sexual dysfunction when added to SSRI therapy.

Herbal Supplements: St. John's Wort

  • Avoid with serotonin medications (SSRIs/SNRIs) due to increased risk of serotonin syndrome.

  • Serotonin syndrome signs/symptoms: Shivering, seizures, tremors, tachycardia, agitation.

    • Emergency requiring immediate referral.

Anxiety

Mnemonic for Anxiety Symptoms: WATCHERS

  • Worry

  • Anxiety

  • Tension

  • Concentration difficulty

  • Hyperarousal

  • Energy loss

  • Restlessness

  • Sleep disturbance

Generalized Anxiety Disorder (GAD)

  • Symptoms must be:

    • Excessive

    • Difficult to control

    • Cause functional impairment

    • Last at least six months

Screening Tool: GAD-2

  • A score of 3 or greater warrants follow-up with the GAD-7.

First-Line Medications for GAD

  • SSRIs and SNRIs.

Adjunct Anxiety Medication

  • Buspirone (Buspar): Not a controlled substance. Can be dosed as needed or consistently

Benzodiazepines

  • For situational anxiety (e.g., fear of flying) or short-term bridge therapy.

  • Caution advised due to serious side effects (CNS depression) and risk of dependence.

Post-Traumatic Stress Disorder (PTSD)

  • Develops in response to a traumatic event or experience.

  • Key symptoms: Nightmares, flashbacks, hypervigilance.

  • Management: Medication and cognitive behavioral therapy (both first-line).

  • Preferred Medication Class: SSRIs.

Insomnia

  • Characterized by difficulty falling asleep, staying asleep, or both.

  • Leads to daytime sleepiness and impairment.

  • Initial Treatment: Patient education about sleep hygiene, followed by cognitive behavioral therapy.

  • Medications:

    • Over-the-counter (OTC): Benadryl, melatonin.

    • FDA-approved medications (use cautiously due to side effects).

    • Non-benzodiazepine receptor agonists (e.g., Ambien): Can cause CNS depression and complex sleep behaviors (sleep driving).

Bipolar Disorder

  • Characterized by extreme mood episodes.

  • Mania (Bipolar I):

    • Reduced sleep, impulsive purchases, racing thoughts, extreme excitement.

  • Followed by low mood symptoms.

  • First-Line Medication: Lithium (mood stabilizer).

    • Prescribed by mental health clinicians.

    • Narrow therapeutic range: 0.6 - 1.2

    • Levels
      less 1.5 indicate risk of toxicity.

  • Lithium Toxicity Symptoms: Nausea, vomiting, tremors, hyperactive reflexes, confusion, vision changes.

  • Monitor thyroid gland (long-term use can lead to hypothyroidism).

Antipsychotics

  • Used for schizophrenia, mood disorders, treatment-resistant depression.

  • Not prescribed by primary care clinicians.

  • Typical (First Generation): Haldol (haloperidol).

  • Atypical (Second Generation): Zyprexa (olanzapine), Seroquel (quetiapine).

  • Metabolic Side Effects: Weight gain, hyperglycemia, hyperlipidemia (monitor regularly).

Pharmacodynamics

  • Majority of medications metabolized in the liver via cytochrome P450 (CYP450) enzymes.

  • Many psych medications are metabolized by CYP3A4, leading to potential drug interactions.

    • St. John's Wort: CYP3A4 inducer (decreases efficacy of drugs like warfarin, digoxin).

  • CYP2C19 enzyme activity varies across populations, affecting metabolism of SSRIs.

    • Genetic variants in some Asian populations may cause different metabolism, effectiveness, or side effects.

  • Asian patients may have cytochrome p450 2C19 poor metabolizer genes causing certain SSRIs like escitalopram (lexapro) to not work. They may require higher dosing or different meds